TYSABRI Lifts Biogen (BIIB) to Q4 Beat; FY12 Outlook is Muted
Tweet
Share
E-mailGet Alerts BIIB Hot Sheet
Price: $216.78 +1.13%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Shares of Biogen Idec, Inc. (Nasdaq: BIIB) are trading higher Tuesday following strong fourth-quarter numbers but light guidance.
Fourth-quarter revenue rose 8.8 percent from $1.22 billion in the same period last year to $1.33 billion.
Net income increased 25 percent to $300.24 million, or $1.22 per diluted share. Adjusted for certain one-time expenses like stock options and asset amortization, net income was $1.51 per share in the quarter, beating views calling for earnings of $1.49 per share.
Global in-market sales of TYSABRI in the fourth quarter of 2011 rose 14 percent to $380 million. The total was comprised of $196 million in U.S. sales and $183 million in sales outside the U.S.
Biogen sees fiscal 2012 non-GAAP earnings of $6.10 to $6.20 per share, versus the consensus of $6.32.
Biogen shares are up 1.4 percent early Tuesday.
Fourth-quarter revenue rose 8.8 percent from $1.22 billion in the same period last year to $1.33 billion.
Net income increased 25 percent to $300.24 million, or $1.22 per diluted share. Adjusted for certain one-time expenses like stock options and asset amortization, net income was $1.51 per share in the quarter, beating views calling for earnings of $1.49 per share.
Global in-market sales of TYSABRI in the fourth quarter of 2011 rose 14 percent to $380 million. The total was comprised of $196 million in U.S. sales and $183 million in sales outside the U.S.
Biogen sees fiscal 2012 non-GAAP earnings of $6.10 to $6.20 per share, versus the consensus of $6.32.
Biogen shares are up 1.4 percent early Tuesday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Bernstein remains bullish on SpaceX but sees challenges in telecom ambitions
- CoStar Group acquires Zonda for $800M, adding new home data
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
